Statistics for Heidelberg Pharma AG (id:2810 HPHA)
Valuation metrics
Market cap
113.72M
Enterprise value
72.84M
Trailing P/E (ttm)
-4.95
Forward P/E
-5.30
PEG ratio
-5.30
Price/Sales (ttm)
13.42
Price/Book (mrq)
3.05
Enterprise Value/Revenue
8.60
Enterprise Value/EBITDA
-3.45
Overview
Shares outstanding
46.60M
Float
8.64M
Shares short
% Held by insiders
3.00%
% Held by institutions
5.00%
Average volume (10 days)
3.74K
Average volume (90 days)
Price summary
52-Week low
2.12
52-Week high
3.95
52-Week change
-73.39%
Beta
3.00
50-Day moving average
2.45
200-Day moving average
2.69
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
July 18, 2014
Financials
Fiscal yearFiscal year ends
November 30, 2023
Most recent quarter (mrq)
August 31, 2024
Profitability
Profit margin
-221.51%
Operating margin
-603.97%
Operational effectiveness
Return on assets
-19.45%
Return on equity
-42.99%
Income statement
Revenue (ttm)
3.00
Revenue per share (ttm)
3.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
6.61M
EBITDA
-21,095,890.00
Net income to common (ttm)
-18,766,690.00
Diluted EPS (ttm)
3.00
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
36.57M
Total cash per share (mrq)
3.00
Total debt (mrq)
159.22K
Total Debt/Equity (mrq)
3.00
Current ratio (mrq)
600.60%
Book value per share (mrq)
3.00
Cash flow
Cash flow statement
-29,926,508.00
Levered free cash flow (LFCF)
-23,428,924.00